Similar articles

• PACAP-(6-38) inhibits the effects of vasoactive intestinal polypeptide, but not PACAP, on the small intestinal circular muscle.

  Lázár Z, Shahbazian A, Benkó R, Tóth G, Penke B, Barthó L, Holzer P. Lázár Z, et al. Eur J Pharmacol. 2001 Nov 16;431(2):259-64. doi: 10.1016/s0014-2999(01)01451-0. Eur J Pharmacol. 2001. PMID: 11728434
• Pituitary adenylate cyclase activating polypeptide (PACAP) is a potent relaxant of the rat ileum.

  Katsoulis S, Clemens A, Schwörer H, Creutzfeldt W, Schmidt WE. Katsoulis S, et al. Peptides. 1993 May-Jun;14(3):587-92. doi: 10.1016/0196-9781(93)90149-b. Peptides. 1993. PMID: 8101370
• PACAP inhibits spontaneous contractions in the intestine of the Atlantic cod, Gadus morhua.

  Olsson C, Holmgren S. Olsson C, et al. Ann N Y Acad Sci. 1998 Dec 11;865:512-4. doi: 10.1111/j.1749-6632.1998.tb11226.x. Ann N Y Acad Sci. 1998. PMID: 10026090 No abstract available.
• Multiple receptors for PACAP and VIP.

  Harmar T, Lutz E. Harmar T, et al. Trends Pharmacol Sci. 1994 Apr;15(4):97-9. doi: 10.1016/0165-6147(94)90042-6. Trends Pharmacol Sci. 1994. PMID: 7912462 Review. No abstract available.
• PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.

  Inagaki N, Kuromi H, Seino S. Inagaki N, et al. Ann N Y Acad Sci. 1996 Dec 26;805:44-51; discussion 52-3. doi: 10.1111/j.1749-6632.1996.tb17472.x. Ann N Y Acad Sci. 1996. PMID: 8993392 Review.